Literature DB >> 318577

Antacid and placebo produced similar pain relief in duodenal ulcer patients.

R A Sturdevant, J I Isenberg, D Secrist, J Ansfield.   

Abstract

The effectiveness of antacid and placebo in relieving single episodes of spontaneous duodenal ulcer pain were compared in two double blind, controlled, randomized trials. The trials compared the effects on ulcer pain of individual doses of a liquid antacid and placebo, rather than the effects of therapeutic regimens with antacid or placebo. Thirty patients were studied. There were no significant differences between antacid and placebo in time to onset, degree, or duration of pain relief. These results suggest that factors other than gastric acid neutralization are important in acute relief of spontaneous duodenal ulcer pain.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 318577

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  16 in total

Review 1.  Drugs in the treatment of gastric and duodenal ulcer.

Authors:  M J Langman
Journal:  Drugs       Date:  1977-08       Impact factor: 9.546

Review 2.  Antacids and peptic ulcer--a reappraisal.

Authors:  T Morris; J Rhodes
Journal:  Gut       Date:  1979-06       Impact factor: 23.059

3.  Effect of placebo on meal-stimulated gastric acid secretion and serum gastrin concentration. Studies in healthy volunteers and duodenal ulcer patients.

Authors:  M Feldman; C T Richardson
Journal:  Dig Dis Sci       Date:  1988-02       Impact factor: 3.199

Review 4.  Current therapy in peptic ulcer.

Authors:  I N Marks
Journal:  Drugs       Date:  1980-10       Impact factor: 9.546

5.  Treatment of peptic ulcer disease- a symposium.

Authors:  J H Meyer; A Schwabe; J I Isenberg; R A Sturdevant; M I Grossman; E Passaro
Journal:  West J Med       Date:  1977-04

6.  Biofeedback in the treatment of gastrointestinal disorders.

Authors:  W E Whitehead
Journal:  Biofeedback Self Regul       Date:  1978-12

7.  Controlled therapeutic trial to determine the optimum dose of antacids in duodenal ulcer.

Authors:  N Kumar; J C Vij; A Karol; B S Anand
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

8.  Anti-ulcer therapy. Past to present.

Authors:  A Bettarello
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199

9.  Is there a place in the United Kingdom for intensive antacid treatment for chronic peptic ulceration?

Authors:  R Faizallah; H A De Haan; N Krasner; R J Walker; A I Morris; M J Calam; D A Budgett
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-06

10.  Acid perfusion of duodenal ulcer craters and ulcer pain: a controlled double blind study.

Authors:  J Y Kang; I Yap; R Guan; H H Tay
Journal:  Gut       Date:  1986-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.